More people are being diagnosed with and dying from cancer, but this is largely the result of declines in mortality from other causes.
Although significant progress has been made in treating cancer, >1.6 million Americans are projected to receive a cancer diagnosis in 2013.
Increased exposure to air pollution during pregnancy and the first year of life is associated with an increased risk of pediatric acute lymphoblastic leukemia, germ cell tumors, and retinoblastoma.
In contemporary practice, medical oncologists use novel anticancer agents on-label more often than off-label.
Significant differences have been identified in the return-to-work (RTW) process for male and female cancer survivors.
Oral monotherapy with moxifloxacin is as efficacious and safe as combination therapy with ciprofloxacin plus amoxicillin/clavulanic acid for treatment of fever in adult patients with cancer and neutropenia who are at low risk of complications.
Oncology patients with lower income, even older patients with access to Medicare, are significantly less likely to participate in clinical trials.